论文部分内容阅读
本刊１９９９年第２期刊登了冯来坤等作者撰写的“从理论角度看免疫核糖核酸的疗效”一文后，收到了清华大学郑昌学教授所著的“从实验、临床和理论看免疫核糖核酸——与‘从理论角度看免疫核糖核酸的疗效’一文作者探讨”文章，现刊登如下。 本编辑部认为免疫核糖核酸的研究和临床实践虽已经历了三十多年，但尚处在发展、完善阶段。由于各人所处研究角度不同，发表不同观点是正常的，特别是其生产工艺、质量控制和活性测定等方面，作为一种药物应当更深入研究，以使该药做得更好。欢迎读者对这一问题展开讨论。
Published in 1999 issue 2 of 1999 and other writers Fenglaikun written “theory from the perspective of the efficacy of RNA” article, received a professor at Tsinghua University, Zheng Changxue “from the experimental, clinical and theoretical view of the immune RNA - And ”from a theoretical point of view of the efficacy of immunological ribonucleic acid" article author explore the article, are published below. The editorial department that the immune RNA research and clinical practice has gone through more than 30 years, but still in the development and improvement stage. Due to the different research perspectives of different people, it is normal to express different viewpoints. In particular, its production process, quality control and activity determination should be further investigated as a drug to make the drug better. Welcome readers to discuss this issue.